National governments have done much to encourage innovation, often through a web of tax incentives for research. Yet, by and large, they have done too little to ensure that these ideas are translated into new businesses, new products, additional jobs, and so, in time, a faster rate of economic growth. "What Europe has to offer biotechnology companies: Unraveling the tax, financial and regulatory framework" is a joint report by Ernst Et Young and EuropaBio. In it, we examine what European countries have to offer investors, entrepreneurs and researchers alike. We look at everything from what to take into account when determining the best location for research and development (R&D) to how best to exploit intellectual property (IP) within Europe's various jurisdictions.
展开▼
机译：各国政府经常通过税收激励措施来鼓励研究，以鼓励创新。但是，总的来说，他们所做的工作很少，无法确保将这些想法转化为新业务，新产品，增加工作机会，从而及时地实现更快的经济增长。 Ernst Et Young和EuropaBio联合发表的报告“欧洲必须为生物技术公司提供的服务：阐明税收，金融和监管框架”。在其中，我们研究了欧洲国家为投资者，企业家和研究人员提供的服务。我们从确定最佳研发位置（R＆D）时要考虑的内容到如何在欧洲各个司法管辖区最有效地利用知识产权（IP）的所有方面进行研究。
展开▼
